Beregnet på helsepersonell

Skriv ut siden
Dokumentasjon på Lyrica



Epilepsi:

Title Lead Author Journal/Reference
Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Arroyo S Epilepsia. 2004 Jan;45(1):20-7.
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. French JA Neurology. 2003 May 27;60(10):1631-7.
Pregabalin: as adjunctive treatment of partial seizures. (Abstract) Warner G CNS Drugs. 2005;19(3):265-72; discussion 273-4.
Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Miller R Clin Pharmacol Ther. 2003 Jun;73(6):491-505.
Pregabalin pharmacology and its relevance to clinical practice. (Abstract) Ben-Menachem E Epilepsia. 2004;45 Suppl 6:13-8.


Smerte:

Title Lead Author Journal/Reference
Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Dworkin RH Neurology. 2003 Apr 22;60(8):1274-83.
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Sabatowski R Pain. 2004 May;109(1-2):26-35.
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Rosenstock J Pain. 2004 Aug;110(3):628-38.
Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Lesser H Neurology. 2004 Dec 14;63(11):2104-10.

 

 

Generell angslidelse:

Title Lead Author Journal/Reference
The effecacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6 week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. Montgomery SA J Clin Psyhiatry.      2005;67:771-782
Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. Pohl RB J clin Psychopharmacol. 2005;25:151-158
Pregabalin for treatment of generalizedanxiety disorder: a 4-week, multicenter,double-blind,placebo-controlled trial of pregabalin and alprazolam. Rickels K Arch Gen Psychiatry. 2005;62:1022-1030
Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Pande A Am J Psychiatry.   2003;160:533-540

 

 

Sist oppdatert 7. sept. '09


Pfizer AS, Postboks 3, 1324 Lysaker | Tlf: 67 52 61 00 Faks: 67 52 61 99| Behandling av personopplysninger | Informasjon om cookies